Patents by Inventor Dong Heon Lee

Dong Heon Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180137215
    Abstract: Provided are an electronic apparatus and a method of operating the electronic apparatus. The electronic apparatus includes a processor configured to acquire space data regarding a target space, generate property information regarding the target space, corresponding to properties of at least one object in the target space, based on the acquired space data, specify a space of interest in the target space, and determine at least one recommendation object to be placed in the specified space of interest based on the generated property information regarding the target space and a plurality of pieces of property information regarding a plurality of sample spaces; and an output interface configured to output the at least one recommendation object.
    Type: Application
    Filed: November 16, 2017
    Publication date: May 17, 2018
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Dong-heon LEE, Chan-woo PARK, Yoo-jeong LEE, Jang-won LEE, Dae-yeon JEONG
  • Publication number: 20170345850
    Abstract: This invention relates to an exfoliation layer composed of a cationic polymer electrolyte or organosilane and negatively charged phyllosilicate sheet-shaped nanoparticles, and to a method of manufacturing the exfoliation layer, including a) negatively charging the surface of a substrate, b) applying a cationic polymer electrolyte or performing a silanization process, and c) negatively charging and applying phyllosilicate. Since the exfoliation layer of the invention has an effect of reducing bonding force due to the sheet-shaped nanoparticles therein, the exfoliation layer enables a flexible display to be temporarily fixed on a supporting substrate upon fabrication of the flexible display and to then be easily separated after the completion of the fabrication thereof.
    Type: Application
    Filed: December 2, 2015
    Publication date: November 30, 2017
    Inventors: Dong Heon LEE, Jeong Seok KIM
  • Patent number: 9817472
    Abstract: Embodiments disclose a display apparatus which processes an image signal to display and a control method thereof, the display apparatus including: a display device; an image processing device with processes an image signal to display an image on the display device; a detection device with detects a motion of a user; and a controller which moves a pointer corresponding to the motion detected by the detection device in a preset first mode, the pointer being displayed on the image, and moves the pointer in a preset second mode, which is different from the first mode, in response to a distance between a position where the motion is detected by the detection device and the display apparatus being changed.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: November 14, 2017
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Dong-heon Lee, Kwan-min Lee, Sang-hee Lee, Chang-soo Lee
  • Patent number: 9753561
    Abstract: A display apparatus including: a display unit; an image processor which processes an image signal to display an image on the display unit; a communication unit which communicates with an input apparatus including a button and a touch pad; and a controller which controls the image processor to display a first item corresponding to a current setting state of the display apparatus in response to a first input from the input apparatus through manipulation of the button and to display at least one second item to be selected to change the current setting state on the display unit in response to a second input from the input apparatus through the touch pad, subsequent to the first input.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: September 5, 2017
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Dong-heon Lee, Yong-hwan Kwon
  • Patent number: 9720528
    Abstract: A display apparatus including: a display unit; an image processor which processes an image signal to display an image on the display unit; a communication unit which communicates with an input apparatus including a button and a touch pad; and a controller which controls the image processor to display a first item corresponding to a current setting state of the display apparatus in response to a first input from the input apparatus through manipulation of the button and to display at least one second item to be selected to change the current setting state on the display unit in response to a second input from the input apparatus through the touch pad, subsequent to the first input.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: August 1, 2017
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Dong-heon Lee, Yong-hwan Kwon
  • Publication number: 20170211057
    Abstract: The present invention relates to a vector comprising a polynucleotide encoding a modified glutamine synthetase (GS), and a method for preparing a target protein employing the same. More particulary, the present invention relates to a modified GS having an increased sensitivity to a glutamine synthetase (GS) inhibitor, a polynucleotide encoding the modified GS, a vector comprising the polynucleotide, a transformat comprising the vector, and a method for preparing a target protein using the transformat.
    Type: Application
    Filed: January 5, 2017
    Publication date: July 27, 2017
    Inventors: Hyun Sook Jang, Dong Heon Lee, Sun Kyu Kim, Yong Ho Ahn, Sang Kyung Park
  • Patent number: 9598483
    Abstract: The present invention relates to a novel monoclonal antibody that binds specifically to delta-like ligand (DLL4), and more particularly to a monoclonal antibody that binds specifically to human delta-like ligand 4 to effectively inhibit the interaction between delta-like ligand 4 and Notch receptor, a polynucleotide encoding the monoclonal antibody, an expression vector comprising the polynucleotide, a transformant comprising the expression vector, a method for preparing the monoclonal antibody, a pharmaceutical composition for preventing or treating cancer comprising the monoclonal antibody, a composition for diagnosing cancer comprising the monoclonal antibody, a method for diagnosing cancer using the monoclonal antibody, and a pharmaceutical composition for preventing or treating autoimmune disease comprising the monoclonal antibody.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: March 21, 2017
    Assignee: ABLBIO
    Inventors: Eun A. Kim, Sang Kyung Park, Kyung Duk Moon, Dong Heon Lee, Yu Bin Choi, Dong In Kim, Kyung Jae Kang
  • Patent number: 9567577
    Abstract: The present invention relates to a vector comprising a polynucleotide encoding a modified glutamine synthetase (GS), and a method for preparing a target protein employing the same. More particularly, the present invention relates to a modified GS having an increased sensitivity to a glutamine synthetase (GS) inhibitor, a polynucleotide encoding the modified GS, a vector comprising the polynucleotide, a transformant comprising the vector, and a method for preparing a target protein using the transformant.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: February 14, 2017
    Assignee: ARES TRADING S.A.
    Inventors: Hyun Sook Jang, Dong Heon Lee, Sun Kyu Kim, Yong Ho Ahn, Sang Kyung Park
  • Publication number: 20160281106
    Abstract: The present invention relates to a bicistronic expression vector for antibody expression, an animal cell transfected with the expression vector, and a method for producing an antibody including culturing the animal cell, in which the expression vector includes a first expression cassette including ‘promoter-UTR-intron-antibody light chain gene-polyA’ and a second expression cassette including ‘promoter-UTR-intron-antibody heavy chain gene-internal ribosome entry site (IRES)-amplification gene-polyA’. An expression vector capable of expressing a desired antibody with high efficiency can be constructed using the bicistronic expression vector including an intron for antibody expression according to the present invention, and the expression vector can produce the antibody by culturing the transfected animal cell with stability and high efficiency.
    Type: Application
    Filed: October 7, 2014
    Publication date: September 29, 2016
    Inventors: Soo Kwang Kim, Young Min Kim, Yong Gyu Son, Yong Ho Ahn, Dong Heon Lee, Yang Soon Lee, Hee Jung Jun, Yu Bin Choi, Eun A Kim
  • Patent number: 9425745
    Abstract: A buffer circuit may include an amplification reference voltage generation unit and an amplification unit. The amplification reference voltage generation unit may generate an amplification reference voltage. The amplification reference voltage generation unit configured to change a level of the amplification reference voltage based on a level of an output signal. The amplification unit may generate the output signal by differentially amplifying an input signal and the amplification reference voltage.
    Type: Grant
    Filed: March 24, 2015
    Date of Patent: August 23, 2016
    Assignee: SK hynix Inc.
    Inventors: Dong Heon Lee, Jin Ha Hwang
  • Patent number: 9411488
    Abstract: A display apparatus and a method for controlling a display apparatus thereof are provided. The method for controlling the display apparatus includes: receiving a mode start command from one of a plurality of input units to control a pointer; determining a type of an input unit through which the mode start command is input; and displaying the pointer on a display screen based on a result of the determining. Accordingly, a user may perform the functions of the display apparatus more conveniently according to each input apparatus.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: August 9, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Jung-geun Kim, Dong-heon Lee, Sung-hyun Jang, Jae-kwon Kim
  • Patent number: 9369750
    Abstract: An electronic device and data control method are provided. The electronic device includes a connector which is connected to an external storage medium storing media data therein; an identification unit which identifies a storage identifier (ID) of the external storage medium connected to the connector; and a controller which performs a media function corresponding to the media data stored in the external storage medium whose storage ID is identified by the identification unit.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: June 14, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Hyeon-ji Lee, Chang-soo Lee, Sang-hee Lee, Dong-heon Lee, Joon-ho Phang, Yeo-ri Yoon
  • Publication number: 20160159929
    Abstract: The present invention relates to a novel dual-targeting protein comprising: a protein that binds specifically to delta-like ligand 4 (DLL4); and an antibody that binds specifically to vascular endothelial cell growth factor (VEGF).
    Type: Application
    Filed: July 8, 2014
    Publication date: June 9, 2016
    Inventors: Dong Heon Lee, Kyung Duk Moon, Yu Bin Choi, Kyung Jae Kang, Dong In Kim, Jin Hyung Ahn, Weon Kyoo You, Jinwon Jung
  • Publication number: 20160164465
    Abstract: A buffer circuit may include an amplification reference voltage generation unit and an amplification unit. The amplification reference voltage generation unit may generate an amplification reference voltage. The amplification reference voltage generation unit configured to change a level of the amplification reference voltage based on a level of an output signal. The amplification unit may generate the output signal by differentially amplifying an input signal and the amplification reference voltage.
    Type: Application
    Filed: March 24, 2015
    Publication date: June 9, 2016
    Inventors: Dong Heon LEE, Jin Ha HWANG
  • Patent number: 9342168
    Abstract: An input apparatus, a display apparatus, a control method thereof and a display system are provided. The input apparatus includes: a communication unit which communicates with the display apparatus; a touch sensor which senses a touch input; a motion sensor which senses a motion of the input apparatus; and a controller which determines whether a value of a touch input, that sensed by the touch sensor when the input apparatus operates in a gesture mode according to the motion of the input apparatus, is greater than or equal to a first reference value, and changes an input mode of the input apparatus to a touch mode if it is determined that the value of the touch input greater than or equal to the first reference value.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: May 17, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Dong-heon Lee, Yong-hwan Kwon
  • Patent number: 9282167
    Abstract: A display device and a control method thereof are provided. The display device includes: a touch screen which displays a screen and senses a gesture of a user on the screen; a video processor which process an image for displaying the screen; a communication unit which performs communication with at least one neighboring device; and a controller which performs control to display a miniature image of a screen of contents being displayed and a first user interface (UI) item showing a connected neighboring device of the at least one neighboring device if a first gesture of a user is made while displaying the screen corresponding to predetermined contents, and to transmit information for sharing the contents to the corresponding neighboring device in accordance with a second gesture of a user with regard to the miniature image and the first UI item.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: March 8, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Sun-haeng Jo, Gyung-hye Yang, Dong-heon Lee, Jung-geun Kim, Soo-Yeoun Yoon, Yoo-tai Kim
  • Patent number: 9249219
    Abstract: The present invention relates to human monoclonal antibodies neutralizing vascular endothelial growth factor receptor and the use thereof. More specifically, relates to human ScFv molecules neutralizing vascular endothelial growth factor receptor, and a composition for inhibiting angiogenesis and a composition for treating cancer, which contain the human ScFv molecules. The disclosed monoclonal antibody neutralizing vascular endothelial growth factor receptor shows excellent neutralizing ability in living cells, compared to that of a commercially available antibody against vascular endothelial growth factor receptor, and shows the ability to neutralize vascular endothelial growth factor receptor not only in humans, but also in mice and rats. Thus, the monoclonal antibody will be useful in anticancer studies and will be highly effective in cancer treatment.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: February 2, 2016
    Assignee: PHARMABCINE INC.
    Inventors: Jin-San Yoo, Weon-Sup Lee, Sang-Ryeol Shim, Mi-Hee Park, Jeong-Eun Kang, Do-Yun Kim, Joon-Chul Lee, Dong-Heon Lee, Too-Hyon Cho, Sam-Sook Sul, Young-Guen Kwon, Bo-Jeong Pyun, Kwi-Hwa Kim, Chae-Ok Yun, Nahm-Ju Kim, Jae-Won Jeon, Dong-Sup Lee, Young-Woo Park, Geun-Bae Rha, Hyun-Sook Jang, Hyeon-Mi Yoo, Sung-Woo Kim, Semi Kim, Sang-Seok Koh
  • Patent number: 9249220
    Abstract: The present invention relates to human monoclonal antibodies neutralizing vascular endothelial growth factor receptor and the use thereof. More specifically, relates to human ScFv molecules neutralizing vascular endothelial growth factor receptor, and a composition for inhibiting angiogenesis and a composition for treating cancer, which contain the human ScFv molecules. The disclosed monoclonal antibody neutralizing vascular endothelial growth factor receptor shows excellent neutralizing ability in living cells, compared to that of a commercially available antibody against vascular endothelial growth factor receptor, and shows the ability to neutralize vascular endothelial growth factor receptor not only in humans, but also in mice and rats. Thus, the monoclonal antibody will be useful in anticancer studies and will be highly effective in cancer treatment.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: February 2, 2016
    Assignee: PHARMABCINE INC.
    Inventors: Jin-San Yoo, Weon-Sup Lee, Sang-Ryeol Shim, Mi-Hee Park, Jeong-Eun Kang, Do-Yun Kim, Joon-Chul Lee, Dong-Heon Lee, Too-Hyon Cho, Sam-Sook Sul, Young-Guen Kwon, Bo-Jeong Pyun, Kwi-Hwa Kim, Chae-Ok Yun, Nahm-Ju Kim, Jae-Won Jeon, Dong-Sup Lee, Young-Woo Park, Geun-Bae Rha, Hyun-Sook Jang, Hyeon-Mi Yoo, Sung-Woo Kim, Semi Kim, Sang-Seok Koh
  • Publication number: 20150326907
    Abstract: An electronic device and data control method are provided. The electronic device includes a connector which is connected to an external storage medium storing media data therein; an identification unit which identifies a storage identifier (ID) of the external storage medium connected to the connector; and a controller which performs a media function corresponding to the media data stored in the external storage medium whose storage ID is identified by the identification unit.
    Type: Application
    Filed: July 22, 2015
    Publication date: November 12, 2015
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Hyeon-ji LEE, Chang-soo LEE, Sang-hee LEE, Dong-heon LEE, Joon-ho PHANG, Yeo-ri YOON
  • Patent number: 9150650
    Abstract: The present invention relates to human monoclonal antibodies neutralizing vascular endothelial growth factor receptor and the use thereof. More specifically, relates to human ScFv molecules neutralizing vascular endothelial growth factor receptor, and a composition for inhibiting angiogenesis and a composition for treating cancer, which contain the human ScFv molecules. The disclosed monoclonal antibody neutralizing vascular endothelial growth factor receptor shows excellent neutralizing ability in living cells, compared to that of a commercially available antibody against vascular endothelial growth factor receptor, and shows the ability to neutralize vascular endothelial growth factor receptor not only in humans, but also in mice and rats. Thus, the monoclonal antibody will be useful in anticancer studies and will be highly effective in cancer treatment.
    Type: Grant
    Filed: June 26, 2007
    Date of Patent: October 6, 2015
    Assignee: PHARMABCINE INC.
    Inventors: Jin-San Yoo, Weon-Sup Lee, Sang-Ryeol Shim, Mi-Hee Park, Jeong-Eun Kang, Do-Yun Kim, Joon Chul Lee, Dong-Heon Lee, Too-Hyon Cho, Sam-Sook Sul, Young-Guen Kwon, Bo-Jeong Pyun, Kwi-Hwa Kim, Chae-Ok Yun, Nahm-Ju Kim, Jae-Won Jeon, Dong-Sup Lee, Young-Woo Park, Geun-Bae Rha, Hyun-Sook Jang, Hyeon-Mi Yoo, Sung-Woo Kim, Se-mi Kim, Sang-Seok Koh